Theracurmin®

Effects of Theracurmin® consumption on liver function, fatigue, and sleep: a randomized, double-blind, placebo-controlled, parallel-comparison study.

Kuwabara Y, Hirose A, Lee HJ, Hashimoto D, Iio SI, and Takara T.

Functional Food in Health and Disease 2021 11; (6): 246-269.

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.

Cancer Chemother Pharmacol. 2012 Jan; 69 (1): 65-70.

Nano-Curcumin Inhibits Proliferation of Esophageal Adenocarcinoma Cells and Enhances the T Cell Mediated Immune Response.

Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, Krishnadath KK.

Front Oncol. 2013 May 29; 3: 137.

Highly bioavailable curcumin (Theracurmin): its development and clinical application.

Imaizumi A.

PharmaNutrition. 2015 Oct; 3 (4): 123–130.

Theracurmin^® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.

Kang M, Ho JN, Kook HR, Lee S, Oh JJ, Hong SK, Lee SE, Byun SS.

Oncol Rep. 2016 Mar; 35 (3): 1463-1472. doi org/10.3892/or.2015.4537.

Novel Curcumin Oral Delivery Systems.

Kurita T, Makino Y.

Anticancer Res. 2013; 33 (7): 2807-2822.